Consensus statement: using epoetin alfa to decrease the risk of allogeneic blood transfusion in the surgical setting. Roundtable of Experts in Surgery Blood Management.
Messmer
K
K
Klinikum Grosshadern, University of Munich, Germany.
D000740:Anemia / Q000188:drug therapy / Q000517:prevention & control; D001803:Blood Transfusion; D001804:Blood Transfusion, Autologous; D006348:Cardiac Surgical Procedures; D000075202:Contraindications; D017558:Elective Surgical Procedures; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006400:Hematocrit; D006801:Humans; D008297:Male; D011292:Premedication; D011994:Recombinant Proteins; D013997:Time Factors
D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa